Nalmefene induced elevation in serum prolactin in normal human volunteers: partial kappa opioid agonist activity? (Q28259148)

1

0 references

James H Schluger

2

0 references

Lisa Borg

3

0 references

Ann Ho

4

0 references

Jean M Bidlack

Alteration of ethanol self-administration by naltrexone.

5

0 references

language of work or name

English

0 references

publication date

December 2005

0 references

published in

Neuropsychopharmacology

0 references

volume

30

0 references

issue

12

0 references

page(s)

2254-62

0 references

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

A multi-site dose ranging study of nalmefene in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Suppressed Prolactin Response to Dynorphin A1–13 in Methadone-Maintained Versus Control Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Mu-opioid receptor binding measured by [11C]carfentanil positron emission tomography is related to craving and mood in alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Presynaptic mu-opioid receptors regulate a late step of the secretory process in rat ventral tegmental area GABAergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Comparison of the discriminative and neuroendocrine effects of centrally penetrating kappa-opioid agonists in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Apparent efficacy of kappa-opioid receptor ligands on serum prolactin levels in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Chronic administration of nalmefene leads to increased food intake and body weight gain in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Hormonal effects of high dose naloxone in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

High-dose naloxone infusions in normals. Dose-dependent behavioral, hormonal, and physiological responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Morphine and endorphins modulate dopamine turnover in rat median eminence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Evidence that D2 receptor-mediated activation of hypothalamic tuberoinfundibular dopaminergic neurons in the male rat occurs via inhibition of tonically active afferent dynorphinergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Effects of heroin and naltrexone on plasma prolactin levels in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Sustained effects of opioid antagonism during the normal human luteal phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Kappa opioid inhibition of morphine and cocaine self-administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Kappa-opioid receptors and relapse-like drinking in long-term ethanol-experienced rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Effects of naltrexone on the subjective response to amphetamine in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Intravenous cocaine challenges during naltrexone maintenance: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Medical complications in methadone patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

The psychopharmacologic and prolactin response after large doses of naloxone in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

The selective kappa-opioid receptor agonist U50,488H attenuates voluntary ethanol intake in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

U50,488, a kappa opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

A double-blind, placebo-controlled pilot study to evaluate the efficacy and safety of oral nalmefene HCl for alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Acute effects of nalmefene on LH, prolactin, and testosterone in male rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Use of naltrexone as a provocative test for hypothalamic-pituitary hormone function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Naltrexone effects on ethanol consumption and response to ethanol conditioned cues in C57BL/6 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Antagonism by naltrexone of voluntary alcohol selection in the chronically drinking macaque monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Anterior pituitary hormone responses to a kappa-opioid agonist in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Cyclazocine: comparison to hydromorphone and interaction with cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Follow-up after a six-month maintenance period on naltrexone versus placebo in heroin addicts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Naltrexone and relapse prevention treatment for cocaine-dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Evaluation of the Sites of Opioid Influence on Anterior Pituitary Hormone Secretion Using a Quaternary Opiate Antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Beta-endorphin-induced locomotor stimulation and reinforcement are associated with an increase in dopamine release in the nucleus accumbens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Naloxone blockade of amphetamine place preference conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Chronic repeated cocaine administration alters basal and opioid-regulated adenylyl cyclase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Chronic cocaine alters brain mu opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Use of positron emission tomography to measure the effects of nalmefene on D1 and D2 dopamine receptors in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

The effects of spiradoline (U-62066E), a kappa-opioid receptor agonist, on neuroendocrine function in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Effects of naloxone infusion on plasma levels of LH, FSH, and in addition TSH and prolactin in males, before and after oestrogen or anti-oestrogen treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Acute "binge" cocaine increases mu-opioid receptor mRNA levels in areas of the rat mesolimbic mesocortical dopamine system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Effect of the endogenous kappa opioid agonist dynorphin A(1-17) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Effect of the kappa opioid agonist R-84760 on cocaine-induced increases in striatal dopamine levels and cocaine-induced place preference in C57BL/6J mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

Effects of mixed-action kappa/mu opioids on cocaine self-administration and cocaine discrimination by rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

7 January 2021

Prolactin: structure, function, and regulation of secretion

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

7 January 2021

The effect of nalmefene on pulsatile secretion of luteinizing hormone and prolactin in men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

7 January 2021

Opioids excite dopamine neurons by hyperpolarization of local interneurons

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

7 January 2021

Endocrine Effects of Naloxone-Induced Opiate Receptor Blockade *

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

7 January 2021

Naloxone effects on ?-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

7 January 2021

Naltrexone and coping skills therapy for alcohol dependence. A controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

7 January 2021

Effects of Exogenous βh-Endorphin on Pituitary Hormone Secretionand Its Disappearance Rate in Normal Human Subjects*

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

7 January 2021

Kappa2 opioid receptors in limbic areas of the human brain are upregulated by cocaine in fatal overdose victims

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

7 January 2021

Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

7 January 2021

Comparison of the duration of action of nalmefene and naloxone on the hypothalamic-pituitary axis of the rhesus monkey

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

7 January 2021

Naloxone antagonism of corticotropin-releasing hormone stimulation of prolactin secretion in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

7 January 2021

Short-term hormonal effects of naloxone in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

7 January 2021

Hormonal and Other Effects of Naltrexone in Normal Men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

7 January 2021

Dopaminergic and serotonergic involvement in opiate-induced prolactin release in monkeys

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300811

7 January 2021